Indegene's share price soared after Axis Direct initiated coverage with a 'buy' recommendation, suggesting an 18% upside. The company's blend of biopharma expertise and AI solutions positions it well for future growth, as per the brokerage firm.
Indegene share price jumps 5% to hit a 52-week high after Axis initiates coverage with a buy - Check target price
Published ·

Keep reading
Related stories






